首页> 外文期刊>Journal of Infectious Diseases >Primary Cytomegalovirus Phosphoprotein 65–Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients
【24h】

Primary Cytomegalovirus Phosphoprotein 65–Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients

机译:原发性巨细胞病毒磷酸蛋白65-特异性CD8 + T细胞反应和T-bet水平预测肺移植受者早期慢性感染期间的免疫控制。

获取原文
           

摘要

Background. Cytomegalovirus (CMV) remains an important pathogen in solid organ transplantation, particularly lung transplantation. Lung transplant recipients (LTRs) mismatched for CMV (donor positive/recipient negative [D+R−]) are at highest risk for active CMV infection and have increased mortality. However, the correlates of immune control during chronic CMV infection remain incompletely understood.
机译:背景。巨细胞病毒(CMV)仍然是实体器官移植特别是肺移植中的重要病原体。 CMV不匹配的肺移植受者(LTR)(供体阳性/受者阴性[D + R -]]处于活动性CMV感染的最高风险,并且死亡率增加。但是,慢性CMV感染期间免疫控制的相关性仍未完全了解。

著录项

  • 来源
    《Journal of Infectious Diseases》 |2011年第11期|p.1663-1671|共9页
  • 作者单位

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland;

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland;

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland;

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号